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The clinical course of coronavirus disease 2019 (COVID-19) varies from mild symp-
toms to acute respiratory distress syndrome, hyperinflammation, and coagulation dis-
order. The hematopoietic system plays a critical role in the observed hyperinflamma-
tion, particularly in severely ill patients. We conducted a prospective diagnostic study
performing a blood differential analyzing morphologic changes in peripheral blood
of COVID-19 patients. COVID-19 associated morphologic changes were defined in
a training cohort and subsequently validated in a second cohort (n = 45). Morpho-
logic aberrationswere further analyzed by electronmicroscopy (EM) and flow cytome-
try of lymphocytes was performed. We included 45 COVID-19 patients in our study
(median age 58 years; 82% on intensive care unit). The blood differential showed a
specific pattern of pronounced multi-lineage aberrations in lymphocytes (80%) and
monocytes (91%) of patients. Overall, 84%, 98%, and 98% exhibited aberrations in
granulopoiesis, erythropoiesis, and thrombopoiesis, respectively. Electron microscopy
revealed the ultrastructural equivalents of the observed changes and confirmed the
multi-lineage aberrations already seen by light microscopy. The morphologic pattern
caused by COVID-19 is characteristic and underlines the serious perturbation of the
hematopoietic system. We defined a hematologic COVID-19 pattern to facilitate fur-
ther independent diagnostic analysis and to investigate the impact on the hematologic
system during the clinical course of COVID-19 patients.
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1 INTRODUCTION
The coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
© 2020 The Authors. eJHaem published by British Society for Haematology and JohnWiley & Sons Ltd.
global challenge in respect of medical therapy as well as widespread
socioeconomic consequences [1,2]. With no vaccine or highly effec-
tive treatment available to date, the major strategies to combat the
disease consist of mitigating transmission by containment efforts as
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well as ameliorating morbidity and mortality in severely ill patients
by drugs limiting viral replication or modulating dysbalanced immune
response [3,4]. In terms of smart containment strategies widespread
testing with high sensitivity and specificity is a prerequisite. However,
the “gold standard” test by real-time polymerase chain reaction (RT-
PCR) takes several hours in time and requires substantial human und
laboratory resources. Moreover, the percentage of false negative pha-
ryngeal samples is quite high partly due to the focused selection of
a single compartment for routine diagnostics [5]. Additional labora-
tory findings supporting diagnosis and enabling follow up diagnostics
to evaluate the course of the disease of COVID-19 would be helpful,
especially when they are everywhere and rapidly available and cost
effective [6].
There is evidence of SARS-CoV-2 affecting multiple organs,
including the hematopoietic and immune system [7,8]. In COVID-19
lymphocytopenia, neutrophilia, eosinopenia, thrombocytopenia, or
thrombocytosis are common findings in blood counts [1,7,9-14]. A
low lymphocyte/neutrophil ratio at diagnosis may be even prognostic
for developing a severe course of disease [8]. Moreover, some studies
report sporadic observations about morphologic changes in peripheral
blood like “reactive” or plasmocytoid lymphocytes, abnormal mono-
cytes/granulocytes/thrombocytes, and leukoerythroblastic reaction
[15-18].
Yet, no systematic evaluation ofmorphologic changes in hematopoi-
etic cells in COVID-19 patients has been performed. Such observed
changes in peripheral blood cells could in principal represent a spe-
cific SARS-CoV-2-mediated impact on hematopoiesis. This assumption
is supported by hematologic findings during other viral diseases (ie,
mononucleosis, dengue fever, etc), which help clinicians to secure a cor-
rect diagnosis [19,20].
Our prospective study aimed to provide a comprehensive descrip-
tion of all morphologic aberrations in blood cells associated with
COVID-19. We demonstrate that a systematic search for this hema-
tologic pattern can provide a straightforward and easy-to-perform
additional diagnostic tool. Moreover, COVID-19-induced hemato-
logic changes might provide hints to what extent the hematopoi-




In this prospective study, 45 patients suffering fromCOVID-19 treated
at the University Hospital Regensburg were included. SARS-CoV-2
infection was confirmed by RT-PCR. The flow cytometric analysis
also included eight healthy sex- and age-matched individuals with
similar age and sex as controls. We obtained epidemiological, demo-
graphic, clinical, laboratory, management, and outcome data from
patients’ medical records. Clinical outcomes were followed up to May
08, 2020. The study was approved by the Ethics Committee of the
University Regensburg (ethics statement No.: 20-1785-101) and writ-
ten informed consent was obtained from all patients and healthy con-
trols. The data that support the findings of this study are available on
request from the corresponding author. The data are not publicly avail-
able due to privacy or ethical restrictions.
2.2 Blood differential
Peripheral blood samples, containing potassium salt of ethylenedi-
aminetetraacetic acid (K2-EDTA) as anticoagulant, were drawn for
diagnostic and/or follow-up purpose. The smears were stained for
light microscopy according to Pappenheim (combination of Jenner-
May-Grünwald and Giemsa). Two laboratory technicians with special
training in hematology, as well as two experienced specialists in
hematology performed microscopic blood differentials according
to standard procedures. Standardized nomenclature and scoring of
cellular features were applied according to the recommendations of
the International Council for Standardization in Haematology (ICSH)
[21]. For the assessment of qualitative aberrations in blood cells a
semi-quantitative scoring system was used, providing 1+ (light), 2+,
3+, and 4+ (highest) grades of alterations. Routine blood differentials
were assessed for distinct SARS-CoV-2 associated changes defined in
the initial training subset. For a clear discrimination of SARS-CoV-2
associated changes in hematopoietic cells from those of other eti-
ologies, the term “aberrant” was used exclusively for COVID-19;
in contrast, the term “reactive/atypical lymphocyte” was applied to
describe lymphocytes with a benign/malignant etiology.
2.3 Electron microscopy
For electron microscopy analyses, leukocytes and mononuclear cells
were isolated from selected whole blood samples by density gradient
centrifugation on Ficoll-Paque. The cell pellet was fixed with buffered
glutaraldehyde (Karnovsky fixative), and then enclosed in low melting
agarose. The embedding process was performed in standardized,
automated manner by use of the LYNX microscopy tissue processor
(Reichert-Jung, Wetzlar, Germany). Semi-thin-sections and ultra-thin
sections (80 nm) were cut using the Reichert Ultracut S Microtome
(Leica-Reichert, Wetzlar, Germany). Ultra-thin-sections were con-
trasted with aqueous 2% uranyl-acetate and 2% lead-citrate solution
for 10 min each. Electron-microscopic analysis was performed using
the EFTEM LEO 912AB electron-microscope (Zeiss, Oberkochen,
Germany).
2.4 Immunophenotyping of circulating
lymphocyte subsets
Adetailed description ofmultiparametric immunophenotyping is given
in the Supporting Information.
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3 RESULTS
3.1 Patient characteristics
The patient cohort consisted of 45 hospitalized patients suffering from
COVID-19. Due to longitudinal sampling, altogether 76 samples were
analyzed (multiple samples in 15 patients, median three samples, range
2-6). The median age was 58 years (ranging from 21 to 77 years) and
most patients were male (Table 1). Notably, the cohort consisted of
severely ill patients. Thirty-seven patients were treated in an intensive
care unit (ICU) of whom 36 needed mechanical ventilation, 11 even
needed extracorporeal membrane oxygenation (ECMO). No antivi-
ral agents were used. Four patients received anakinra due to severe
secondary hemophagocytic lymphohistiocytosis (HLH). In peripheral
blood counts, 41%of the samples showed leukocytosis, 83% lymphocy-
topenia, 88%monocytopenia, 17%thrombocytopenia, and37%throm-
bocytosis. Of note, three patients suffered from chronic lymphocytic
leukemia as concomitant disease. At the time of sample collection,
median duration of disease was 24 days ranging from 6 to 54 days
(Figure S1).
3.2 Alterations in the peripheral blood
3.2.1 Blood differential
The first observations of distinct morphologic changes in blood smears
of COVID-19 patients led to the analysis of an initial (training) cohort
(n = 15 COVID-19 patients). In this initial group of patients, marked
morphologic anomalies in all three hematologic lineages were found
(Figure 1). In particular, “aberrant lymphocytes” differing from reac-
tive lymphocytes that are commonly seen in other viral diseases such
as dengue fever and infectious mononucleosis, as well as “aberrant”
monocytes were observed (Figure 1).Moreover, marked aberrations in
granulo-, erythro-, and thrombopoiesis were also seen (detailed com-
position of aberrations is shown in Table S1).
In order to further evaluate whether these morphologic changes
(Figure 1; Table S1) are associated with COVID-19, we performed a
prospective analysis in a larger cohort of COVID-19 patients using
an “experimental” blood differential in which all suspected COVID-
19 associated aberrations (Table S1) were quantified separately. The
results are demonstrated in Table 2. Median differential counts for
“aberrant” lymphocytes and “aberrant” monocytes were 1% and 3%,
respectively. Pronounced aberrations in all lineages were observed.
In the entire cohort “aberrant” lymphocytes and “aberrant” mono-
cytes were present in 36 patients (80%) and 41 patients (91%),
respectively (Table 3). Interestingly, “classical,” reactive/activated
lymphocyteswere observed only in five patients (9%). In addition, 84%,
98%, and 98% of patients exhibited aberrations in granulopoiesis, ery-
thropoiesis, and thrombopoiesis, respectively. Particularly, anomalies
like Pseudo-Pelger Hüet neutrophils, nucleated red blood cells, and
giant platelets were found frequently showing a serious perturbation
of the entire hematopoiesis with features usually seen in hematologic
TABLE 1 Data of patient demographics, basic laboratory findings
and list of comorbidities
Demographic No. of patients (%)
Patients 45
Samples 76




ICU care 37 (82.0)
On respirator 36 (80)
ECMO 11(24.4)
Laboratory findings Median (min; max)
Leucocytes (nL−1) 8.73 (1.69; 116.15)*
Lymphocytes (nL−1) 1.25 (0.25; 76.66)
Monocytes (nL−1) 0.65 (0.0; 2.74)
Hemoglobin (g/dL) 8.6 (6.9; 13.1)
Platelets (nL−1) 278 (37; 770)
LDH (U/L) 369 (167; 1080)
C-reactive protein (mg/L) 64.35 (3.2; 372)
Procalcitonine (ng/mL) 0.47 (0.06; 27.7)
Comorbidities No. of patients (%)
None 10 (22.2)
Arterial Hypertension 14 (31.1)
Diabetes mellitus 9 (20.0)
Atrial fibrillation 4 (8.9)
Obstructive sleep apnea 4 (8.9)
Carcinoma in patient history 4 (8.9)
Adipositas 3 (6.7)
Chronic lymphocytic leukemia 3 (6.7)
Liver cirrhosis 3 (6.7)
Hypercholesterinemia 2 (4.4)
Hepatitis C 2 (4.4)
Organ transplant 2 (4.4)
Coronary heart disease 2 (4.4)
Non-Hodgkin lymphoma 1 (2.2)
Abbreviations: ECMO, extracorporeal membrane oxygenation; LDH, lac-
tate dehydrogenase.
*The cohort contained three patients with chronic lymphocytic leukemia.
This explains the highmaximum counts of leukocytes.
neoplasms like myelodysplastic syndrome (MDS) and myeloprolifera-
tive neoplasms (MPN). A left shift inmyeloid cells was observed in 67%
of patients.
In our cohort, 14 patients developed negativity for SARS-CoV-2
RNA in respiratory material samples. In order to evaluate whether
the elimination of the virus had any impact on the observed
changes in the peripheral blood, we performed an additional analysis
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F IGURE 1 Morphologic aberrations in blood smears in COVID-19. A and B, Aberrant lymphocytes withmulti-lobulated nuclei and large
cytoplasmatic granula (B); C andD, aberrant lymphoplasmocytoid cells; E, Mott cell; F, enlarged lymphocyte with basophilic cytoplasm, undergoing
apoptosis with signs of karyolysis; G andH, lympho-monocytoid cells with aberrant lobulated nuclei; I and J, monocytes with aberrant nuclei
(clumped chromatin) and basophilic cytoplasms; K and L, left shift withmyelocytes/metamyelocytes (*) and hypergranulation;M, granulocytes with
hypergranulation (*); L andM, (◄) apoptotic cells; N, neutrophil granulocyte with hypolobulated nucleus, pseudo-Pelger-Huët anomaly; O, giant
platelet with cytoplasmic vacuoles; P, giant platelets and aggregated platelets; Q and R, aberrant erythropoiesis: anisocytosis of RBCs, basophilic
stippling (Q◄), stomatocytes (R◄), target-cell and nucleated RBC (←); S, Prussian blue staining showing large iron-containing deposits (◄); T,
patient with CLL: two atypical lymphocytes (←) (CLL) and one large aberrant lymphocyte with basophilic cytoplasm, likely plasmablast with
clumped chromatin(◄), neutrophil granulocyte with hypergranulation and aberrant segmentation of the nucleus
classifying patients/samples as “still SARS-CoV-2 positive” or “after
negative SARS-CoV-2 test.” Comparing these two subgroups, we
observed a significant decrease in the left shift of myeloid cells as well
as a decrease in hypergranulation and the presence of Pseudo-Pelger
Huët neutrophils after virus elimination while all the other anomalies
showed no change (Table 3; Figure S2). Similarly, we observed a sig-
nificant decrease in C-reactive protein (CRP) (Figure S3) representing
a reduction in systemic inflammation. Thus, the left shift and “aber-
rations” in the granulopoiesis might be caused by the SARS-CoV-2-
induced systemic inflammatory response.
3.2.2 Electron microscopy
To assess the ultrastructural equivalents of the distinctive aberrations
seen by light microscopy, electron microscopy on peripheral blood
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TABLE 2 Light microscopic blood differential blood smears of
COVID-19 patients
Cell Type Median (min; max)
Blasts (%) 0 (0; 2)
Promyelocytes (%) 0 (0; 4)
Myelocytes (%) 0.5 (0; 5)
Metamyelocytes (%) 0 (0; 9)
Band neutrophils (%) 2.5 (0; 32)
Segmented neutrophils (%) 72 (5; 89)
Eosinophils (%) 1 (0; 31)
Basophils (%) 0 (0; 2)
Aberrant basophils (%) 0 (0; 5)
Lymphocytes* (%) 11.5 (0; 52)
aberrant lymphocytes* (%) 1 (0; 23)
Atypical lymphocytes* (%) 0 (2; 66)
Reactive lymphocytes (%) 0 (0; 2)
Plasma cells (%) 0 (0; 2)
Monocytes (%) 5 (0; 15)
Aberrant Monocytes (%) 3 (0; 8)
Erythroblasts (per 100WBC) 0 (0; 22)
Morphologic feature Median (min; max)
Apoptosis − (−;++)
Hypergranulated neutropils + (−;+++)
Hypogranulated neutrophils − (−;+)
Neutrophils with Pelger-Huët nuclear alteration − (−;++)
Döhle Bodies − (−;+)
Polychromasia of red blood cells + (−;++)
Anisocytosis of red blood cells + (−;+++)
Macrocytosis of red blood cells − (−;++)
Microcytosis of red blood cells + (−;++)
Stomatocytes − (−;+++)
Rouleaux formation − (−;+++)
Aanisocytosis of platelets + (−;+++)
Giant platelets + (−;++)
*The cohort contained three patients with chronic lymphocytic leukemia.
This explains the high maximum counts of lymphocytes and atypical lym-
phocytes.
cells was performed. In transmission electron microscopy, numerous
lymphocytes showed markedly nuclear invaginations, sometimes
containing cell organelles such as mitochondria (Figure 2). In addition,
lymphocytes with highly lobulated nuclei were found. Interestingly,
elongated lymphocytes could be demonstrated. Furthermore, we
could confirm the finding of giant platelets. Among normal platelets
1.5-3 µm in diameter, enlarged platelets with a dimension of >5 µm
were also present. Finally, we identified granulocytes in early stages of
apoptosis, exhibiting hypercondensed chromatin and the beginning of
nuclear shrinking.
3.2.3 Quantitative alterations of circulating
lymphocyte subpopulations
In addition to the microscopic leukocyte differential, a quantitative
analysis of lymphocytes, regarding their major subpopulations, was
performed. Relative T cells counts (as % of leucocytes) were signifi-
cantly lower in the COVID-19 group than in the healthy control group.
There was no difference between the two groups in respect of abso-
lute T cell and B cell counts. Interestingly, there was a significantly
lower absolute NK cell count in the COVID-19 group as compared to
the healthy control group (Table S2). In addition to the quantification
of circulating lymphocyte subpopulations, cell surface expression of
all major antigens (ie, CD3, CD4, CD5, CD8) on T cells and their sub-
sets were determined by flow cytometry. We found significant higher
expression of CD3, CD5, and CD8 on the CD8+ T cell subpopulation
in the COVID-19 group, as compared to the healthy control group
(Figure S4).
4 DISCUSSION
Our morphologic observations reveal that COVID-19 is associated
with hematologic multi-lineage changes of all cellular components of
the peripheral blood, that is, lymphocytes, monocytes, granulocytes,
erythrocytes, and platelets. This is consistent with previous, sporadic
reports describing particular aspects like abnormal lymphocytes, plas-
mocytoid cells, monocytes, granulocytic, or leukoerythroblastic reac-
tions in COVID-19 patients [15-18]. Interestingly, while other virus
infections (eg, Epstein-Barr virus orDengue fever) are known to induce
morphologic changes in lymphocytes (termed “reactive lymphocytes”
or “virocytes”), these “classical” reactive lymphocytes were found only
infrequently in COVID-19 patients in our study cohort [19,20]. Elec-
tron microscopic investigations revealed the ultrastructural equiva-
lents of the observed changes like nuclear invaginations or apoptotic
cells and confirmed the multi-lineage aberrations already seen by light
microscopy.
The observed multi-lineage hematologic changes are very helpful
to shed light on the complex pathophysiology leading to the severe
disease pattern in COVID-19 as our morphological findings in the
peripheral blood could reflect the complex immune dysregulation in
COVID-19 patients with respiratory failure [3]. The aberrations in the
myeloid compartment with accelerated and dysplastic granulo- and
monopoiesis resemble changes usually found in MDS or MDS/MPN
and they may indicate a functional derangement possibly related to
hyperinflammation/cytokine release syndrome [22]. “Aberrant” cells
suchasPelger-Huëtneutrophils ormonocytes are very likely tobenon-
/dysfunctional leading to a high susceptibility to secondary bacterial or
fungal infections representing an additional serious threat to the life of
patients, especially for the critically ill [23,24].
In addition to the immune dysregulation, a further characteristic
clinical feature of COVID-19 is the high incidence of thromboem-
bolism [25]. A perturbation of the plasmatic coagulation as well as
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TABLE 3 Frequency of morphologic changes in blood smears of COVID-19 patients
All patients and samples
Still SARS-CoV-2 positive
patients and samples















Aberrant lymphocytes 36 (80) 56 (74) 29 (81) 38 (70) 12 (86) 18 (82)
Aberrant monocytes 41 (91) 69 (91) 32 (89) 48 (89) 14 (100) 21 (95)
Left shift 31 (67) 48 (63) 26 (72) 37 (69) 8 (57) 11 (50)
Aberrant granulopoiesis 38 (84) 64 (84) 32 (89) 47 (87) 11 (79) 17 (77)
Hypergranulation 35 (78) 58 (76) 30 (83) 43 (80) 10 (71) 15 (68)
Pseudo-Pelger Huët neutrophils 21 (47) 30 (39) 19 (53) 25 (46) 4 (29) 5 (23)
Aberrant erythropoiesis 44 (98) 75 (99) 35 (97) 53 (98) 14 (100) 22 (100)
Nucleated red blood cells 9 (20) 16 (21) 8 (22) 11 (20) 3 (21) 5 (23)
Aberrant thrombopoiesis 44 (98) 75 (99) 35 (97) 53 (98) 14 (100) 22 (100)
Giant thrombocytes 39 (87) 67 (88) 30 (83) 46 (85) 14 (100) 21 (95)
Apoptotic cells 17 (38) 22 (29) 14 (39) 14 (26) 6 (43) 8 (36)
endothelial dysfunction possibly caused by inflammation have been
reported as causative events so far [26,27]. The high incidence of
giant platelets (independent of absolute platelet counts) found in this
study might also contribute to hypercoagulability in COVID-19. Giant
platelets are also a common morphologic feature of MPNs, another
group of diseases associated with a high risk for thromboembolism.
Our flow cytometry analyses showed distinct immunophenotypic
alterations of T-lymphocyte subpopulations in the COVID-19 group
consistent with recent reports [14,28,29]. Moreover, we found signif-
icant higher antigen expression for CD3, CD5, and CD8 on the CD8+
T cell subpopulation in the COVID-19 group as compared to healthy
controls that may reflect a hyperactivation of CD8+ T cells in severe
SARS-CoV-2 infection. Significantly elevatedCD8expression onT cells
has also been observed in a recently published COVID-19 cohort and
others described that T-lymphocytes can also be directly infected by
SARS-CoV-2 [30,31].
The occurrence ofmulti-lineagemorphologic changes in the periph-
eral blood gives rise to the question how hematopoiesis, in particular
hematopoietic progenitor cells, could be involved in COVID-19 patho-
genesis: as a direct target of SARS-CoV-2 via infection and/or indirectly
via pro-inflammatory cytokine burst. The fact that only mild morpho-
logic changes in the granulopoiesis like the left shift improved along
with decreasing systemic inflammation in the “after negative SARS-
CoV-2 test” cohort points out that there is a prolonged alteration of
the hematopoiesis beyond short-term inflammation. Thus, systematic
long-term follow up will be very important to analyze the recovery of
the hematopoietic system. Particularly for patients starting/resuming
cytostatic or immunosuppressive therapy this should be a prereq-
uisite. This will also allow investigating if COVID-19 patients have
a higher susceptibility for secondary hematologic or other immune
diseases.
The observed complexity and the extent of multi-lineage morpho-
logic changes are not found in any other virus infection, thus here
constituting a hematologic COVID-19 pattern that seems to be clini-
cally suitable for a systematic scoring system. Since peripheral blood
smears are easily obtained, rapidly performed, and cost-effective, this
approachwould be particularly helpful when SARS-CoV-2 RNA testing
is not available (for instance in developing countries). Complementary
morphologic analysis might also corroborate diagnosis in cases with
typical pulmonary infiltrates by computed tomography (CT) scan
and negative SARS-CoV-2 PCR test. Moreover, the peripheral blood
smears could also easily be used for follow-up analysis and long-term
evaluations investigating the impact on the hematopoietic system.
Thus, one clinical implication of our findings could be to further
investigate this pattern in a larger cohort of patients at different time
points in order to develop a morphologic scoring system that assists
the diagnosis and follow-up of SARS-CoV-2 infection. For validation
purposes, for example, a blinded study evaluation of blood differentials
in a general population presenting in the emergency room with respi-
ratory symptoms could be one approach. Since little or almost nothing
is known about hematologic changes in patients with asymptomatic
or mildly symptomatic SARS-CoV-2 infection, this cohort should also
be investigated. To discriminate between virus specific changes and
alterations due to systemic inflammation or secondary infection a
comparison our observations in COVID-19 patients to patients in
ICU care due to a different severe respiratory infection like influenza
would be very helpful as well as longitudinal analysis on the temporal
occurrence in the course of disease.
To the best of our knowledge, this is the first prospective study
reporting a hematologic COVID-19 pattern consisting of aberrations
in all blood cell lineages. Primarily, the observed changes further illus-
trate the complex immunedysregulation inducedbyCOVID-19and the
involvement of the hematopoietic system in the pathogenesis of the
disease. Second, this pattern might be further investigated and vali-
dated by a blinded, unbiased approach in a larger cohort giving rise to
the development of amorphologic COVID-19 scoring system.
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F IGURE 2 Representative ultrastructural changes of aberrant cells. A, Lymphocyte with invagination of the cytoplasm (arrowhead) containing
amitochondrion (arrow). B, Lymphocyte with highly lobulated nucleus. C,Markedly elongated lymphocyte. D and E, Ultrastructural change of
platelets and granulocytes: D, a mixture of normally sized platelets (arrows) and giant platelets (E) was obvious. F, Granulocyte, showing apoptosis
with nuclear pycnosis with shrinking (arrowhead) and chromatin condensation (*)
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